Study type: Epidemiological study (observational study)

Use of wireless phones and the risk of salivary gland tumours: a case-control study epidem.

Published in: Eur J Cancer Prev 2012; 21 (6): 576-579

Aim of study (acc. to author)

A case-control study was conducted in Sweden to investigate the association between the use of wireless phones (mobile phones and cordless phones) and the risk of salivary gland tumor.

Further details

In the present publication data were analyzed that were collected in the years after the previous study by Hardell et al. (2004) on the topic had ended.
Participants who started their use of a mobile phone or cordless phone within one year prior diagnosis were classified as unexposed.

Endpoint/type of risk estimation

Type of risk estimation: (odds ratio (OR))

Exposure

Assessment

Exposure groups

Group Description
Reference group 1 no wireless phone use
Group 2 analog mobile phone, ≤ 52 h, > 1 year latency
Group 3 analog mobile phone, ≤ 52 h, > 1 - 5 year latency
Group 4 analog mobile phone, ≤ 52 h, > 5 - 10 year latency
Group 5 analog mobile phone, ≤ 52 h, > 10 year latency
Group 6 analog mobile phone, > 52 h, > 1 year latency
Group 7 analog mobile phone, > 52 h, > 1 - 5 year latency
Group 8 analog mobile phone, > 52 h, > 5 - 10 year latency
Group 9 analog mobile phone, > 52 h, > 10 year latency
Group 10 digital mobile phone, ≤ 69 h, > 1 year latency
Group 11 digital mobile phone, ≤ 69 h, > 1 - 5 year latency
Group 12 digital mobile phone, ≤ 69 h, > 5 - 10 year latency
Group 13 digital mobile phone, ≤ 69 h, > 10 year latency
Group 14 digital mobile phone, > 69 h, > 1 year latency
Group 15 digital mobile phone, > 69 h, > 1 - 5 year latency
Group 16 digital mobile phone, > 69 h, > 1 - 5 year latency
Group 17 digital mobile phone, > 69 h, > 10 year latency
Group 18 mobile phone, ≤ 66 h, > 1 year latency
Group 19 mobile phone, ≤ 66 h, > 1 - 5 year latency
Group 20 mobile phone, ≤ 66 h, > 1 - 5 year latency
Group 21 mobile phone, ≤ 66 h, > 10 year latency
Group 22 mobile phone, > 66 h, > 1 year latency
Group 23 mobile phone, > 66 h, > 1 - 5 year latency
Group 24 mobile phone, > 66 h, > 5 - 10 year latency
Group 25 mobile phone, > 66 h, > 10 year latency
Group 26 cordless phone use, ≤ 304 h, > 1 year latency
Group 27 cordless phone use, ≤ 304 h, > 1 - 5 year latency
Group 28 cordless phone use, ≤ 304 h, > 5 -10 year latency
Group 29 cordless phone use, ≤ 304 h, > 10 year latency
Group 30 cordless phone use, > 304 h, > 1 year latency
Group 31 cordless phone use, > 304 h, > 1 - 5 year latency
Group 32 cordless phone use, > 304 h, > 5 - 10 year latency
Group 33 cordless phone use, > 304 h, > 10 year latency
Group 34 wireless phone use, ≤ 273 h, > 1 year latency
Group 35 wireless phone use, ≤ 273 h, > 1 - 5 year latency
Group 36 wireless phone use, ≤ 273 h, > 5 -10 year latency
Group 37 wireless phone use, ≤ 273 h, > 10 year latency
Group 38 wireless phone use, > 273 h, > 1 year latency
Group 39 wireless phone use, > 273 h, > 1 - 5 year latency
Group 40 wireless phone use, > 273 h, > 5 -10 year latency
Group 41 wireless phone use, > 273 h, > 10 year latency
Group 42 analog mobile phone use: 1 - 1000 h
Group 43 analog mobile phone use: 1001 - 2000 h
Group 44 analog mobile phone use: > 2000 h
Group 45 digital mobile phone use: 1 - 1000 h
Group 46 digital mobile phone use: 1001 - 2000 h
Group 47 digital mobile phone use: > 2000 h
Group 48 mobile phone use: 1 - 1000 h
Group 49 mobile phone use: 1001 - 2000 h
Group 50 mobile phone use: > 2000 h
Group 51 cordless phone use: 1 - 1000 h
Group 52 cordless phone use: 1001 - 2000 h
Group 53 cordless phone use: > 2000 h
Group 54 wireless phone use: 1 - 1000 h
Group 55 wireless phone use: 1001 - 2000 h
Group 56 wireless phone use: > 2000 h

Population

Case group

Control group

Study size

Cases Controls
Eligible 78 312
Participants 69 262
Participation rate 88 % 83 %
Other:

63 out of 69 patients had parotid gland tumors

Statistical analysis method: (adjustment: )

Results (acc. to author)

36 patients with salivary gland tumor (52%) and 149 control subjects (57%) reported using a wireless phone; mobile phone use (30 cases and 111 controls) was somewhat more common than cordless phone use (19 cases and 93 controls) among both cases and controls.
The use of wireless phones (mobile phones and cordless phones) was not associated with an overall increased risk of salivary gland tumors (OR 0.8; CI 0.4-1.5). There was neither an increased risk for the different phone types when calculated separately nor an increased risk for different latencies or different categories of cumulative use. The overall results were similar for the risk of parotid gland tumors. The authors conclude that their results add the evidence against there being an increased risk for parotid gland tumors associated with light-to-moderate use of wireless phones and for less than 10 years of use.

Study funded by

Related articles